Literature DB >> 18812042

Treatment adherence of the latently infected tuberculosis population (post-Katrina) at Wetmore TB Clinic, New Orleans, USA.

J Bieberly1, J Ali.   

Abstract

OBJECTIVES: To conduct a survey of the working of the Wetmore TB Clinic and to evaluate and analyze the follow-up data of the patient population diagnosed with latent TB infection (LTBI) at the Louisiana Office of Public Health (OPH) Region 1 Wetmore TB Clinic.
METHODS: This data analysis, initiated as a student practicum course, is based on a chart review of patients attending the Wetmore TB Clinic between 1 January 2006 and 30 June 2007. Only those patients with a diagnosis of LTBI were included in the survey. RESULT: The total survey population in this data analysis consisted of 380 LTBI patients. Results were analyzed for demographic data, TB risk factors, referral sources and treatment outcomes. Forty-three per cent of all the patients with LTBI displayed at least one of these risk factors. Adherence rates for LTBI treatment were low, at 19%.
CONCLUSIONS: Post-Katrina New Orleans presents a challenging environment for TB control. This study forms a basis for further planning, provision and evaluation of services to this population. Its results and conclusions could be reflective of similar issues pertaining to public health TB clinics in other cities where displacement of patients, movement of migratory transient workers and disbanded infrastructure due to natural or man-made disasters could pose a problem.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18812042

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

Review 1.  Medication adherence in Hispanics to latent tuberculosis treatment: a literature review.

Authors:  Julie Ann Zuñiga
Journal:  J Immigr Minor Health       Date:  2012-02

Review 2.  Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology.

Authors:  Joseph M Cicchese; Stephanie Evans; Caitlin Hult; Louis R Joslyn; Timothy Wessler; Jess A Millar; Simeone Marino; Nicholas A Cilfone; Joshua T Mattila; Jennifer J Linderman; Denise E Kirschner
Journal:  Immunol Rev       Date:  2018-09       Impact factor: 12.988

3.  Stigma and Therapy Completion for Latent Tuberculosis among Haitian-origin Patients.

Authors:  Jeannine Coreil; Michael Lauzardo; Heather Clayton
Journal:  Fla Public Health Rev       Date:  2010-04-08

Review 4.  A scoping review of paediatric latent tuberculosis infection care cascades: initial steps are lacking.

Authors:  Jeffrey I Campbell; Thomas J Sandora; Jessica E Haberer
Journal:  BMJ Glob Health       Date:  2021-05

5.  Coping with tuberculosis and directly observed treatment: a qualitative study among patients from South India.

Authors:  Vijayashree Yellappa; Pierre Lefèvre; Tullia Battaglioli; Devadasan Narayanan; Patrick Van der Stuyft
Journal:  BMC Health Serv Res       Date:  2016-07-19       Impact factor: 2.655

6.  Effect of removing the barrier of transportation costs on surgical utilisation in Guinea, Madagascar and the Republic of Congo.

Authors:  Mark G Shrime; Mirjam Hamer; Swagoto Mukhopadhyay; Lauren M Kunz; Nathan H Claus; Kirsten Randall; Joannita H Jean-Baptiste; Pierre H Maevatombo; Melissa P S Toh; Jasmin R Biddell; Ria Bos; Michelle White
Journal:  BMJ Glob Health       Date:  2017-09-26

7.  Prevalence of Tuberculosis in Children After Natural Disasters, Bohol, Philippines.

Authors:  Kristy O Murray; Nina T Castillo-Carandang; Anna M Mandalakas; Andrea T Cruz; Lauren M Leining; Salvacion R Gatchalian
Journal:  Emerg Infect Dis       Date:  2019-10       Impact factor: 6.883

8.  Tuberculosis exposure among evacuees at a shelter after earthquake, Japan, 2011.

Authors:  Hajime Kanamori; Noboru Aso; Satoko Tadano; Miyoko Saito; Hiroo Saito; Bine Uchiyama; Noriomi Ishibashi; Shinya Inomata; Shiro Endo; Tetsuji Aoyagi; Masumitsu Hatta; Mitsuhiro Yamada; Yoshiaki Gu; Koichi Tokuda; Hisakazu Yano; Hiroyuki Kunishima; Yoichi Hirakata; Takao Saijyo; Miho Kitagawa; Mitsuo Kaku
Journal:  Emerg Infect Dis       Date:  2013-05       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.